Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sumatriptan naproxen sodium tablets for acute migraine
CTR20180199Phase 3Active
- Sponsor
- Nanjing Huawei Pharmaceutical Technology Development
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sumatriptan + naproxen sodium in migraine without aura, sponsored by Nanjing Huawei Pharmaceutical Technology Development. Started Feb 2018; status: active.
02
Drugs
sumatriptan + naproxen sodium
03
Conditions
migraine without aura
Beyond the preview
Go deeper on CTR20180199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180199.